Impact of COVID|19 on Pre| and Early|Commercial Biopharmas

Impact of COVID-19 on Pre- and Early-Commercial Biopharmas

The scorecard approach used by many pre-commercial biopharmas for bonus payouts should help mitigate the potential for a down year in any one ...

Biopharma innovation trends during COVID-19 and beyond

Collaboration and capital investment are crucial for biopharmaceutical drug development, as early innovation is often driven by academic ...

How COVID-19 has affected Big Pharma and biotech

Sizing up COVID-19's impact. But some biopharma executives don't think COVID-19 is changing how companies think of M&As. “The appetite for ...

COVID-19 Changed the Biopharma Industry - and There's No Going ...

The pandemic has also had a significant impact on the biopharma industry. ... commercial and government entities as they studied the ...

Covid-19 Impact on Bioprocessing - Biopharma.com

We need to keep in mind that the pre-pandemic R&D and products manufacturing ... commercial manufacturing. Expect this investment to boost those ...

Biopharma strategy after COVID-19 | Deloitte Insights

Breaking barriers to digitalization in biopharma. The pandemic's impact on R&D and commercial operating models. Ken Burows. United ...

Winning against COVID-19: The implications for biopharma

How companies act individually and collectively in the next few weeks and months will shape the outcome of the pandemic and the reputation ...

COVID-19 and Commercialization - IQVIA

COVID-19 is forcing brands to re-evaluate commercial strategies. Whether pre-launch, launch or in-market, IQVIA is helping brands address current challenges ...

Impact of COVID-19 on pharmaceutical external innovation sourcing

Although there has clearly been a short-term disruption to biopharma deals, the relative health of the early innovation landscape ...

The impact of COVID-19 on biopharma's productivity conundrum

... biopharma. We discussed how the adoption of novel approaches such as pre-competitive knowledge sharing, unparalleled levels of collaboration ...

Drug Manufacturing Trends Impacting Biopharma Stakeholders in ...

Pre-pandemic: The emergence of advanced therapeutic modalities. Early clinical trial success signaled a need for novel manufacturing ...

The impact of COVID-19: a catalyst for change, innovation and ...

Key Points · COVID-19 has been a catalyst for change, innovation and investment across the biopharmaceutical industry. · The pandemic has propelled telehealth ...

Biopharma set for COVID-related single-use shortages, says survey

Single-use bioprocessing technologies now dominate the pre-commercial manufacturing space according to research by Bioplan Associates. ... impact of the ...

Outlook for Biopharma Financing and Deals During the COVID-19 ...

The debt market will take some time to come back as many healthcare credit funds have investment in commercial stage companies that have been ...

A year with COVID-19: The impact of data on pharma marketing

Working with Crossix, the brand was able to see early data and discovered that there was an 8% reduction in new-to-brand prescription fills ( ...

Opinion: Prepare Your Biopharma for the Next Pandemic ... - BioSpace

Although the urgency and devastating toll of the early COVID-19 pandemic ... I encourage biopharma leaders to reflect on the massive impact of ...

Navigating Covid turbulence: How biopharmas are adapting their go ...

Biopharma manufacturers must also consider the financial impact of the pandemic on its patients. ... commercial challenges of the coronavirus ...

6 Biopharma CFOs Discuss The Pandemic's Impact On The Supply ...

... commercial model post-COVID. HOW HAS THE ... pre-COVID travel and commutation activities that can now be effectively be redeployed.

The impact of COVID-19 on the cell and gene therapies industry

... effects on the biopharma industry [35]. GT companies are particularly well ... COVID-19 vaccine, AZD1222, by EMA early in 2021. A German CGT company ...

COVID-19 and commercial pharma: Navigating an uneven recovery

The impact of COVID-19 on hospitals and the heroic contributions of HCPs (and the extreme challenges they face) have been well documented. HCPs, ...